MDH1-IN-2 (7c) is a potent MDH1 inhibitor with an IC50 of 2.27 μM for MDH1 and 27.47 μM for MDH2. MDH1-IN-2 has potential anticancer activity and can be used in the study of diseases related to the immune system.

1,4-Anthraquinone is an anticancer drug that blocks nucleoside transport, inhibits macromolecule synthesis, induces DNA fragmentation.

Pomalidomide-PEG3-OH enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology.